Myotonic Dystrophy Type 1 With Normal-Pressure Hydrocephalus-Like Neuroimaging and a Negative Tap Test: Diagnostic Pitfalls and Management Considerations
Journal of Movement Disorders · 31.10.2026 · 19 (4) · 463-466
DOI: 10.14802/jmd.26029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Movement Disorders, erschienen am 31.10.2026. Verfasst von Deep Faldu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Institute of Mental Health and Neurosciences, India. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Neurology, National Institute of Mental Health and Neurosciences, India.
- Molecular Genetics Laboratory, Department of Psychiatry, National Institute of Mental Health and Neurosciences, India.
Zitieren
APA
Faldu, D., Babu, N., Holla, V. V., Prasad, S., Purushottam, M., Kamble, N., Yadav, R., & Pal, P. K. (2026). Myotonic Dystrophy Type 1 With Normal-Pressure Hydrocephalus-Like Neuroimaging and a Negative Tap Test: Diagnostic Pitfalls and Management Considerations. Journal of Movement Disorders, 19(4), 463-466. https://doi.org/10.14802/jmd.26029
Vancouver
Faldu D, Babu N, Holla VV, Prasad S, Purushottam M, Kamble N, et al. Myotonic Dystrophy Type 1 With Normal-Pressure Hydrocephalus-Like Neuroimaging and a Negative Tap Test: Diagnostic Pitfalls and Management Considerations. Journal of Movement Disorders. 2026;19(4):463-466. doi:10.14802/jmd.26029
BibTeX
@article{Faldu2026,
author = {Faldu, Deep and Babu, Naresh and Holla, Vikram V and Prasad, Shweta and Purushottam, Meera and Kamble, Nitish and Yadav, Ravi and Pal, Pramod Kumar},
title = {Myotonic Dystrophy Type 1 With Normal-Pressure Hydrocephalus-Like Neuroimaging and a Negative Tap Test: Diagnostic Pitfalls and Management Considerations},
journal = {Journal of Movement Disorders},
year = {2026},
volume = {19},
number = {4},
pages = {463--466},
doi = {10.14802/jmd.26029}
}
EUVIMED